Cluster of Differentiation 33 Single Nucleotide Polymorphism Rs12459419 is a Predictive Factor in Patients with Nucleophosmin1-Mutated Acute Myeloid Leukemia Receiving Gemtuzumab OzogamicinKatrin Teich,Julia Krzykalla,Silke Kapp-Schwoerer,Verena I. Gaidzik,Richard F. Schlene,Peter Paschka,Daniela Weber,Walter Fiedler,Michael W. M. Kuhn,Thomas Schroeder,Karin Mayer,Michael Lubbert,Dhanya Ramachandran,Axel Benner,Arnold Ganser,Hartmut Dohner,Michael Heuser,Konstanze Dohner,Felicitas TholHaematologica(2021)引用 6|浏览38AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要